
J&J charts $2.58-B course
Johnson & Johnson is partnering with Sail Biomedicines to advance in vivo CAR-T treatments for immune-mediated diseases, with an exclusive $2.58 billion…
· 1 MIN READ
Topic
Latest Daily Tribune news and analysis on Sail Biomedicines.

Johnson & Johnson is partnering with Sail Biomedicines to advance in vivo CAR-T treatments for immune-mediated diseases, with an exclusive $2.58 billion…
· 1 MIN READ

The Philippines and India will conduct their first joint sail in the West Philippine Sea, following discussions at the Raisina Dialogue. AFP Chief Brawner…
· 2 MIN READ

The Philippine Coast Guard enforces a "No Sail Zone" in Cagayan during the 40th Balikatan Joint Military Exercises to ensure safety during live-fire drills…
· 1 MIN READ
